← Back to Search

You℞ Decision prescribing platform for Implementation Science (IMPROV Trial)

N/A
Waitlist Available
Led By Courtney Peasant Bonner, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months follow-up
Awards & highlights

Summary

This trial will test a new training to reduce stigma around prescribing mental health medication and naltrexone for alcohol use disorder, in order to increase providers' self-efficacy in prescribing these treatments.

Eligible Conditions
  • Implementation Science
  • Substance Use Disorder
  • Mental Health Disorders
  • Stigmatization

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months follow-up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Clinic Staff-Level Outcome: Acceptability of Stigma Reduction Training
Clinic Staff-Level Outcome: Observed Stigma Reduction
Clinic-Level Outcome: Adoption of Psychiatric Medication and Naltrexone
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: YouRx Prescribing Platform OnlyExperimental Treatment1 Intervention
Staff working in the clinic in this arm will not be offered a whole-site stigma reduction training. However, staff will be offered this training at the conclusion of the study. Participating HIV care providers will have access to the YouRx Prescribing Platform.
Group II: Stigma-Reduction Training Arm + YouRx Prescribing PlatformExperimental Treatment2 Interventions
Staff working in the clinic in this arm will be offered a whole-site stigma reduction training. Participating HIV care providers will have access to the YouRx Prescribing Platform.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Modified Health Policy Project (HPP) HIV-Stigma and Discrimination Reduction Training Curriculum
2019
N/A
~810

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
195 Previous Clinical Trials
816,850 Total Patients Enrolled
SisterLove, Inc.OTHER_GOV
1 Previous Clinical Trials
313 Total Patients Enrolled
Positive Impact Health CentersUNKNOWN
2 Previous Clinical Trials
384 Total Patients Enrolled
~102 spots leftby Sep 2025